Amarin Corporation plc

NASDAQ (USD): Amarin Corporation plc (AMRN)

Last Price

0.57

Today's Change

+0.003 (0.52%)

Day's Change

0.565 - 0.583

Trading Volume

780,392

Overview

Market Cap

234 Million

Shares Outstanding

411 Million

Avg Volume

1,544,850

Avg Price (50 Days)

0.52

Avg Price (200 Days)

0.65

PE Ratio

-5.70

EPS

-0.10

Earnings Announcement

26-Feb-2025

Previous Close

0.57

Open

0.57

Day's Range

0.5646 - 0.5834

Year Range

0.43 - 1.36

Trading Volume

780,592

Price Change Highlight

1 Day Change

0.46%

5 Day Change

-1.98%

1 Month Change

8.53%

3 Month Change

-3.75%

6 Month Change

-19.17%

Ytd Change

8.88%

1 Year Change

-53.65%

3 Year Change

-84.08%

5 Year Change

-96.92%

10 Year Change

-46.22%

Max Change

-99.90%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment